Alnylam Pharmaceuticals (ALNY) FY Conference Transcript

Alnylam Pharmaceuticals (ALNY) FY Conference June 09, 2025 09:20 AM ET Speaker0 Great. Good morning, everyone. Thank you so much for joining us. I'm Salveen Richter, biotechnology analyst at Goldman Sachs. We're really pleased to be joined by the Alnylam team. With me, we have Yvonne Greenstreet, CEO, and John Kennedy, head of the TTR franchise. So Yvonne, before we even start, you know, you announced some news this morning, so maybe this is a perfect time point to maybe speak to the European approval that ...